04:49 PM EDT, 03/26/2026 (MT Newswires) -- Krishnaswamy Yeleswaram, Chief Development Officer, on March 25, 2026, sold 10,115 shares in Rapport Therapeutics ( RAPP ) for $303,355. Following the Form 4 filing with the SEC, Yeleswaram has control over a total of 286,876 common shares of the company, with 286,876 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/2012593/000119312526126410/xslF345X05/ownership.xml